N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide

C146H182F6N26O23S7 — CID 158213289

IUPACN-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide
SMILESCC(C)c1cc(F)cc(-c2cccnc2)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)n1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cn(C2CC2)cn1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)c1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)n1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1ncn(C2CC2)n1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(C(C)C)cc(F)cc3C(C)C)nn2C(C)C)COC1.Cc1cc(-c2ccc3c(c2CC(=O)NS(=O)(=O)c2cnn(C4CC4)c2)CCC3)ccn1
InChIInChI=1S/C24H34FN3O5S.C23H24N4O3S.C21H22FN5O3S.2C20H26FN3O3S.2C19H25FN4O3S/c1-14(2)18-8-17(25)9-19(15(3)4)20(18)10-22(29)27-34(30,31)23-11-21(28(26-23)16(5)6)24(32-7)12-33-13-24;1-15-11-17(9-10-24-15)21-8-5-16-3-2-4-20(16)22(21)12-23(28)26-31(29,30)19-13-25-27(14-19)18-6-7-18;1-13(2)17-8-15(22)9-18(14-4-3-7-23-11-14)19(17)10-20(28)26-31(29,30)21-12-24-27(25-21)16-5-6-16;1-12(2)17-7-14(21)8-18(13(3)4)19(17)9-20(25)23-28(26,27)16-10-22-24(11-16)15-5-6-15;1-12(2)16-7-14(21)8-17(13(3)4)18(16)9-19(25)23-28(26,27)20-10-24(11-22-20)15-5-6-15;1-11(2)15-7-13(20)8-16(12(3)4)17(15)9-18(25)23-28(26,27)19-21-10-24(22-19)14-5-6-14;1-11(2)15-7-13(20)8-16(12(3)4)17(15)9-18(25)23-28(26,27)19-10-21-24(22-19)14-5-6-14/h8-9,11,14-16H,10,12-13H2,1-7H3,(H,27,29);5,8-11,13-14,18H,2-4,6-7,12H2,1H3,(H,26,28);3-4,7-9,11-13,16H,5-6,10H2,1-2H3,(H,26,28);2*7-8,10-13,15H,5-6,9H2,1-4H3,(H,23,25);2*7-8,10-12,14H,5-6,9H2,1-4H3,(H,23,25)
InChIKeyGCIJHTWHOKOZHX-UHFFFAOYSA-N
MW3007.68 g/mol
LogP23.28
Rot. Bonds50

About N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide

N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide (PubChem CID 158213289) has the molecular formula C146H182F6N26O23S7 and a molecular weight of 3007.68 g/mol. Its IUPAC name is N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide.

Molecular Properties

Compound NameN-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide
PubChem CID158213289
Molecular FormulaC146H182F6N26O23S7
Molecular Weight3007.68 g/mol
Exact Mass3005.18
IUPAC NameN-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide
SMILESCC(C)c1cc(F)cc(-c2cccnc2)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)n1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cn(C2CC2)cn1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)c1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)n1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1ncn(C2CC2)n1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(C(C)C)cc(F)cc3C(C)C)nn2C(C)C)COC1.Cc1cc(-c2ccc3c(c2CC(=O)NS(=O)(=O)c2cnn(C4CC4)c2)CCC3)ccn1
InChIInChI=1S/C24H34FN3O5S.C23H24N4O3S.C21H22FN5O3S.2C20H26FN3O3S.2C19H25FN4O3S/c1-14(2)18-8-17(25)9-19(15(3)4)20(18)10-22(29)27-34(30,31)23-11-21(28(26-23)16(5)6)24(32-7)12-33-13-24;1-15-11-17(9-10-24-15)21-8-5-16-3-2-4-20(16)22(21)12-23(28)26-31(29,30)19-13-25-27(14-19)18-6-7-18;1-13(2)17-8-15(22)9-18(14-4-3-7-23-11-14)19(17)10-20(28)26-31(29,30)21-12-24-27(25-21)16-5-6-16;1-12(2)17-7-14(21)8-18(13(3)4)19(17)9-20(25)23-28(26,27)16-10-22-24(11-16)15-5-6-15;1-12(2)16-7-14(21)8-17(13(3)4)18(16)9-19(25)23-28(26,27)20-10-24(11-22-20)15-5-6-15;1-11(2)15-7-13(20)8-16(12(3)4)17(15)9-18(25)23-28(26,27)19-21-10-24(22-19)14-5-6-14;1-11(2)15-7-13(20)8-16(12(3)4)17(15)9-18(25)23-28(26,27)19-10-21-24(22-19)14-5-6-14/h8-9,11,14-16H,10,12-13H2,1-7H3,(H,27,29);5,8-11,13-14,18H,2-4,6-7,12H2,1H3,(H,26,28);3-4,7-9,11-13,16H,5-6,10H2,1-2H3,(H,26,28);2*7-8,10-13,15H,5-6,9H2,1-4H3,(H,23,25);2*7-8,10-12,14H,5-6,9H2,1-4H3,(H,23,25)
InChIKeyGCIJHTWHOKOZHX-UHFFFAOYSA-N
XLogP23.28
TPSA650.33 Ų
H-Bond Donors7
H-Bond Acceptors42
Rotatable Bonds50
Heavy Atoms208
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003007.68
LogP ≤ 523.28
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1042

Analyze N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide?
The IUPAC name of N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide (CID 158213289) is N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide.
What is the SMILES notation for N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide?
The canonical SMILES for N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide is CC(C)c1cc(F)cc(-c2cccnc2)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)n1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cn(C2CC2)cn1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)c1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1cnn(C2CC2)n1.CC(C)c1cc(F)cc(C(C)C)c1CC(=O)NS(=O)(=O)c1ncn(C2CC2)n1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(C(C)C)cc(F)cc3C(C)C)nn2C(C)C)COC1.Cc1cc(-c2ccc3c(c2CC(=O)NS(=O)(=O)c2cnn(C4CC4)c2)CCC3)ccn1.
What is the InChIKey of N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide?
The InChIKey is GCIJHTWHOKOZHX-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H34FN3O5S.C23H24N4O3S.C21H22FN5O3S.2C20H26FN3O3S.2C19H25FN4O3S/c1-14(2)18-8-17(25)9-19(15(3)4)20(18)10-22(29)27-34(30,31)23-11-21(28(26-23)16(5)6)24(32-7)12-33-13-24;1-15-11-17(9-10-24-15)21-8-5-16-3-2-4-20(16)22(21)12-23(28)26-31(29,30)19-13-25-27(14-19)18-6-7-18;1-13(2)17-8-15(22)9-18(14-4-3-7-23-11-14)19(17)10-20(28)26-31(29,30)21-12-24-27(25-21)16-5-6-16;1-12(2)17-7-14(21)8-18(13(3)4)19(17)9-20(25)23-28(26,27)16-10-22-24(11-16)15-5-6-15;1-12(2)16-7-14(21)8-17(13(3)4)18(16)9-19(25)23-28(26,27)20-10-24(11-22-20)15-5-6-15;1-11(2)15-7-13(20)8-16(12(3)4)17(15)9-18(25)23-28(26,27)19-21-10-24(22-19)14-5-6-14;1-11(2)15-7-13(20)8-16(12(3)4)17(15)9-18(25)23-28(26,27)19-10-21-24(22-19)14-5-6-14/h8-9,11,14-16H,10,12-13H2,1-7H3,(H,27,29);5,8-11,13-14,18H,2-4,6-7,12H2,1H3,(H,26,28);3-4,7-9,11-13,16H,5-6,10H2,1-2H3,(H,26,28);2*7-8,10-13,15H,5-6,9H2,1-4H3,(H,23,25);2*7-8,10-12,14H,5-6,9H2,1-4H3,(H,23,25).
What are the key properties of N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide?
N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide has a molecular weight of 3007.68 g/mol, XLogP of 23.28, 50 rotatable bonds, 7 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-cyclopropylimidazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(1-cyclopropylpyrazol-4-yl)sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide;N-[(1-cyclopropyl-1,2,4-triazol-3-yl)sulfonyl]-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;N-(2-cyclopropyltriazol-4-yl)sulfonyl-2-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)acetamide;2-[4-fluoro-2,6-di(propan-2-yl)phenyl]-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide is sourced from PubChem (CID 158213289), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).